Hematogenix Revenue and Competitors

Tinley Park, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Hematogenix's estimated annual revenue is currently $35M per year.(i)
  • Hematogenix's estimated revenue per employee is $238,095

Employee Data

  • Hematogenix has 147 Employees.(i)
  • Hematogenix grew their employee count by 5% last year.

Hematogenix's People

NameTitleEmail/Phone
1
VP Global OperationsReveal Email/Phone
2
Senior Director Scientific AffairsReveal Email/Phone
3
Director ITReveal Email/Phone
4
Laboratory ManagerReveal Email/Phone
5
Operations Manager - UKReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Flowcytometry Lab scientist at HematogenixReveal Email/Phone
8
Flow TechnologistReveal Email/Phone
9
System AdministratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A12222%N/AN/A
#2
N/A26100%N/AN/A
#3
N/A2759%N/AN/A
#4
$35M228136%N/AN/A
#5
$7.5M12156%N/AN/A
#6
$15M13089%N/AN/A
#7
$7.5M727%N/AN/A
#8
N/A855%N/AN/A
#9
N/A814%N/AN/A
#10
N/A936%N/AN/A
Add Company

What Is Hematogenix?

Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant

keywords:N/A

N/A

Total Funding

147

Number of Employees

$35M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M1566%N/A
#2
$18.3M166-2%N/A
#3
$34.5M1749%N/A
#4
$51.7M207N/AN/A
#5
$60.1M21541%N/A